Abstract:Psoriasis is a common skin disease affecting 1-3% of the population (Gelfand et al., 2005; Ferrándiz et al., 2001). Approximately 30% of patients with psoriasis develop psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis (Haroon et al., 2013; Prey et al., 2010). Generalized pustular psoriasis (GPP) affects about 1.3% of psoriasis patients. Recently, numerous novel susceptibility loci for psoriasis vulgaris (PsV) have been discovered thorough the application of genome-wide association studies (GWASs). Among them, the major histocompability complex is the locus with the strongest effect. Outside the major histocompability complex region, the novel susceptibility loci of PsV can be incorporated into an integrated pathogenic model comprising distinct signaling networks affecting skin barrier function, innate immune responses involving NF-κB signaling, and adaptive immune responses involving CD8 T cells and IL-23/IL-17-mediated lymphocyte signaling. Compared with PsV, only three GWASs were performed in PsA (Ellinghaus et al., 2012; Hüffmeier et al., 2010; Stuart et al., 2015), accompanied with other candidate gene studies, most of the PsA susceptibility loci have been proved to be associated with PsV. However, the genetic study of GPP is quite different. Up to now, IL36RN is the only associated gene of GPP that has been widely verified. The data are based on homozygosity mapping and direct sequencing in consanguineous Tunisian multiplex families with autosomal recessive GPP (Marrakchi et al., 2011). Some researchers suggested that GPP and PsV are etiologically distinct clinical entities (Capon, 2013), challenging the traditional understanding of psoriasis. The percentages of IL36RN-negative patients have been reported to range from 51% (Li et al., 2013) to 84% (Setta-Kaffetzi et al., 2013), implying that additional risk loci, genetic interactions, and other factors may account for the other GPP cases. Recently, more than 10 GWASs of PsV have identified a number of susceptibility loci, making PsV GWASs a rich source of potential risk loci for other subtypes of psoriasis. Here, we use information emerging form PsV GWASs to make inferences about the genetic etiology of PsA and GPP in a Chinese population.

An update on genetic basis of generalized pustular psoriasis (Review)

Understanding the Pathogenesis of Generalized Pustular Psoriasis Based on Molecular Genetics and Immunopathology

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis

A review of disease burden and clinical management for generalized pustular psoriasis in China

Considerations for defining and diagnosing generalized pustular psoriasis

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment

The update of treatment strategies in pediatrics with generalized pustular psoriasis in China

Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis

Diagnosis of Generalized Pustular Psoriasis

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares

Increased neutrophil‐derived IL‐17A identified in generalized pustular psoriasis

New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors

Biologics for generalized pustular psoriasis: a systematic review and single-arm meta-analysis

Investigation of Psoriasis Susceptibility Loci in Psoriatic Arthritis and a Generalized Pustular Psoriasis Cohort

Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management

Pustular Psoriasis: From Pathophysiology to Treatment

Generalized Pustular Psoriasis and Systemic Organ Dysfunctions

Knowledge Mapping and Research Hotspots of Generalized Pustular Psoriasis: A Bibliometric Analysis from 2003 to 2023

Genetic analysis of different subtypes of Aseptic pustulosis in the Chinese population

Clinical Course and Characteristics of Generalized Pustular Psoriasis